ArticleFrontiers in pharmacology2021
Open access · goldAbstract read
In one paragraph
Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 30 citations in OpenAlex.
- Next-Generation Immune Checkpoints and Tumor Microenvironment Modulation in Cancer Immunotherapy.Journal of immunology research · 2026Review
- Oncolytic virotherapy and tumor microenvironment modulation.Clinical and experimental medicine · 2025Review
- Oncogenic viruses rewire the epigenome in human cancer.Frontiers in cellular and infection microbiology · 2025Review
- Peripheral clocks and systemicFrontiers in endocrinology · 2025Review
- The human microbiome in clinical translation: from bench to bedside.Frontiers in microbiology · 2025Review
- Global analysis of actionable genomic alterations in thyroid cancer and precision-based pharmacogenomic strategies.Frontiers in pharmacology · 2025Article
- TCellSI: A novel method for T cell state assessment and its applications in immune environment prediction.iMeta · 2024Article
- Unraveling druggable cancer-driving proteins and targeted drugs using artificial intelligence and multi-omics analyses.Scientific reports · 2024Article
- CardiOmics signatures reveal therapeutically actionable targets and drugs for cardiovascular diseases.Heliyon · 2024Article
- Integrated multi-omics analysis reveals the molecular interplay between circadian clocks and cancer pathogenesis.Scientific reports · 2023Article
- Clinical and pulmonary function analysis in long-COVID revealed that long-term pulmonary dysfunction is associated with vascular inflammation pathways and metabolic syndrome.Frontiers in medicine · 2023Article
- The close interaction between hypoxia-related proteins and metastasis in pancarcinomas.Scientific reports · 2022Article
- Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials.Frontiers in pharmacology · 2022Article
- Current treatment strategies for COVID‑19 (Review).Molecular medicine reports · 2021Review
- Identification of key proteins in the signaling crossroads between wound healing and cancer hallmark phenotypes.Scientific reports · 2021Article
- Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes).International journal of molecular sciences · 2021Review
- Can proteomics-based approaches further help COVID-19 prevention and therapy?Expert review of proteomics · 2021Article
- Applications of artificial intelligence in battling against covid-19: A literature review.Chaos, solitons, and fractals · 2021Review
- Article
- Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 MMolecules (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors at 10 institutions in 5 countries.
Andrés López-CortésCentro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.
Patricia Guevara-RamírezCentro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.
Nikolaos C KyriakidisOne Health Research Group, Faculty of Medicine, Universidad de Las Américas (UDLA), Quito, Ecuador.
Carlos Barba-OstriaOne Health Research Group, Faculty of Medicine, Universidad de Las Américas (UDLA), Quito, Ecuador.
Ángela León CáceresHeidelberg Institute of Global Health, Faculty of Medicine, Heidelberg University, Heidelberg, Germany.
Santiago GuerreroCentro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.
Esteban Ortiz-PradoOne Health Research Group, Faculty of Medicine, Universidad de Las Américas (UDLA), Quito, Ecuador.
Cristian R MunteanuRNASA-IMEDIR, Computer Science Faculty, University of A Coruna, A Coruña, Spain.
Eduardo TejeraGrupo de Bio-Quimioinformática, Universidad de Las Américas (UDLA), Quito, Ecuador.
Doménica Cevallos-RobalinoHospital General del Sur de Quito, Instituto Ecuatoriano de Seguridad Social, Quito, Ecuador.
Ana María Gómez-JaramilloFaculty of Medicine, Pontifical Catholic University of Ecuador, Quito, Ecuador.
Katherine Simbaña-RiveraOne Health Research Group, Faculty of Medicine, Universidad de Las Américas (UDLA), Quito, Ecuador.
Adriana Granizo-MartínezCarrera de Medicina, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.
Gabriela Pérez-MCentro Clínico Quirúrgico Ambulatorio Hospital del Día El Batán, Instituto Ecuatoriano de Seguridad Social, Quito, Ecuador.
Silvana MorenoDepartment of Plant Biology, Faculty of Natural Resources and Agricultural Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Jennyfer M García-CárdenasCentro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.
Ana Karina ZambranoCentro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.
Yunierkis Pérez-CastilloGrupo de Bio-Quimioinformática, Universidad de Las Américas (UDLA), Quito, Ecuador.
Alejandro Cabrera-AndradeRNASA-IMEDIR, Computer Science Faculty, University of A Coruna, A Coruña, Spain.
Lourdes Puig San AndrésCentro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.
Carolina Proaño-CastroFundación Futuro, Quito, Ecuador.
Jhommara BautistaFacultad de Ingeniería y Ciencias Aplicadas-Biotecnología, Universidad de Las Américas, Quito, Ecuador.
Andreina QuevedoCentro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.
Nelson VarelaLatin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain.
Luis Abel QuiñonesLatin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain.
César Paz-Y-MiñoCentro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.
Universidad UTE · ECUniversidad de Las Américas · ECInstituto de Investigación Biomédica de A Coruña · ESPontificia Universidad Católica del Ecuador · ECUniversity of Chile · CLFundación Para La Investigación Y Gestión En Servicios de Salud · ECHospital General del Sur de Quito, IESSInstituto Ecuatoriano de Enfermedades Digestivas · ECSwedish University of Agricultural Sciences · SEUniversidade da Coruña · ES
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
artificial neural networksCOVID-19drug repurposingimmune systemsingle-cell RNA sequencing
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.